State Street’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
2023
Q2
$22.8K Sell
2023
Q1
$24.3K Hold
2022
Q4
$22K Hold
2022
Q3
$34K Sell
2022
Q2
$41K Sell
2022
Q1
$355K Sell
2021
Q4
$1.07M Buy
2021
Q3
$1.49M Buy
2021
Q2
$2.27M Buy
2021
Q1
$1.89M Buy